Motexafin Gadolinium Injection

TERMINATED · PHASE1 · Head and Neck Cancer, Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.